Detalles de la búsqueda
1.
Aberrant B-cell activation and B-cell subpopulations in rheumatoid arthritis: analysis by clinical activity, autoantibody seropositivity, and treatment.
Clin Exp Immunol
; 214(3): 314-327, 2023 12 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37464892
2.
BNT162b2 Vaccination after SARS-CoV-2 Infection Changes the Dynamics of Total and Neutralizing Antibodies against SARS-CoV-2: A 6-Month Prospective Cohort Study.
Vaccines (Basel)
; 11(6)2023 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37376516
3.
Vitamin D in Depression: A Potential Bioactive Agent to Reduce Suicide and Suicide Attempt Risk.
Nutrients
; 15(7)2023 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37049606
4.
Efficacy and Safety of Heterologous Booster Vaccination after Ad5-nCoV (CanSino Biologics) Vaccine: A Preliminary Descriptive Study.
Vaccines (Basel)
; 10(3)2022 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35335032
5.
Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and without Prior COVID-19 - A Prospective Cohort Study.
J Inflamm Res
; 15: 4449-4466, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35958186
6.
Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing antibodies.
Immunol Lett
; 251-252: 20-28, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36279685
7.
Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2.
Vaccines (Basel)
; 9(9)2021 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34579284
Resultados
1 -
7
de 7
1
Próxima >
>>